Testing a study drug with brain stimulation for treatment-resistant depression
Part of Mental health clinical trials.
This study combines a new experimental medication (NRX-101) with robotic brain stimulation (TMS) to see if it improves depression symptoms. It is for people who have not had success with at least two other depression treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 65 years old.
- You must be starting TMS for the first time.
- You must have been diagnosed with major depressive disorder that has not responded to at least two prior adequate treatments.
- You need a reliable care partner or family member who can support you during the study.
- You must not be pregnant or breastfeeding, and if you can become pregnant, you must agree to use highly effective birth control.
- You must be able to attend all study visits and follow the study plan, including daily text message check-ins.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This program provides access to an investigational medicine called NRX-101 for people with treatment-resistant depression who are also receiving brain stimulation therapy (theta burst TMS). The goal is to see if combining this medicine with TMS can help reduce depression symptoms.
This trial tests a new type of brain stimulation treatment for people with major depression that hasn't improved with standard treatments. The treatment uses magnetic pulses to target specific brain areas over about 2 weeks.
This study tests a new way of delivering brain stimulation called rTMS to treat depression that hasn't improved with standard treatments. The goal is to see if targeting specific brain areas helps reduce depression symptoms more effectively.
This trial tests whether using brain-related “biomarkers” from your scans to guide rTMS can improve depression that hasn’t responded to at least one antidepressant. It may help by targeting brain circuits linked to depression more precisely.
This trial compares different modes of transcranial magnetic stimulation (TMS)—a non-invasive brain stimulation technique—to see which works better for people with treatment-resistant depression. If you've tried multiple antidepressants without relief, this study may offer a new option.
This trial studies signs in the brain (biomarkers) during an accelerated form of nerve stimulation to treat depression that hasn’t improved with usual antidepressants. It may help researchers learn who benefits and how to better personalize treatment.
Hear when a new Treatment Resistant Depression trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.